Brief report| Volume 40, ISSUE 6, P542-543, September 15, 1996

Serum cholesterol and treatment-resistance in schizophrenia

      This paper is only available as a PDF. To read, Please Download here.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ghaeli P
        • Dufresne RL
        Increased serum triglyceride levels in patients treated with clozapine.
        Int Pharmaceutical Abstr. 1994; 31: 2243
        • Hawton K
        • Cowen P
        • Owens D
        • Bond A
        • Elliott M
        Low serum cholesterol and suicide.
        Br J Psychiatry. 1993; 162: 818-825
        • Kahn RS
        • Davidson M
        • Siever L
        • Gabriel S
        • Apter S
        • Davis KL
        Serotonin function and treatment response to clozapine in schizophrenic patients.
        Am J Psychiatry. 1993; 150: 1337-1342
        • Roth BL
        • Meltzer HY
        The role of serotonin in schizophrenia.
        in: Bloom EF Kupfer DJ Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York1995: 1222
        • Silver JA
        The malnourished older patient: When and how to intervene.
        Geriatrics. 1993; 48: 70-74